1:25pm ET
Technology
Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017
Merrill Lynch singled out a group in the tech sector that the firm believes will outperform going forward -- specifically, internet stocks.
Companies
iShares Biotechnology ETF
$214.80
▼ $0.43 (−0.20%) today
Markets closed · 11:03pm ET
IBB Coverage
Page 3
12:10pm ET
Health and Healthcare
Meet Jefferies Top 12 Picks in the Roaring Biotech Industry
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has grown, and…
11:15am ET
Health and Healthcare
3 Sleeper Biotechs That Could Bounce Back Strong in 2017
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
12:40pm ET
Health and Healthcare
Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares
Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments due to his comments.
11:55am ET
Transportation
Why We Could Expect a Zika Rally in These Stocks
We know that the broad markets work on the basis of greed and fear, but we have to ask ourselves whether we have become too afraid of Zika and when we can…
9:35am ET
Health and Healthcare
Capital Infusions Are More Evidence of a Biotech Turnaround
Here are four biotech companies that have just either closed fresh financing rounds or issued IPOs that exceeded price expectations.
7:35am ET
Health and Healthcare
3 Stocks With Catalysts That Could Capitalize on Biotech Momentum
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get an added boost with any good news.
Trey Thoelcke 11:15am ET
Health and Healthcare
Jefferies Identifies 5 Top Biotech Stocks for Huge Upside
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
5:15pm ET
Health and Healthcare
Why Citi Sees Huge Upside in 4 Top Biotechs Now
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
7:10am ET
Health and Healthcare
4 Top Biotech Stocks for 2016
Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better 2016 for this exciting sector?
8:25am ET
Health and Healthcare
The Strongest Performing Biotech in 2015 Is a Surprise
ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the Biotechnology Index is up only 0.3%, pretty much breakeven. While the first…
2:40pm ET
Investing
Technician Picks Oversold Biotechs for Large Potential Trading Bounces
A report on Wednesday from Janney Capital Markets has targeted several iotech bcompanies it believes are now grossly oversold.
1:20pm ET
Health and Healthcare
The Political Tweet That Thrashed the Biotech Sector
On Monday, a simple tweet from presidential candidate Hillary Clinton managed to wreck the biotech sector.
Jon C. Ogg 10:05am ET
Health and Healthcare
CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs
If you missed the biotech run and want to try to catch the train this late in the game, it would be wise not to use the new Proshares leveraged biotech ETFs.
11:35am ET
Health and Healthcare
Will Amgen Earnings Shape Biotech for the Rest of 2015?
After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.
